India's Mid-Market May 2026: Fintech, Synbio, and Deeptech Series A/B Deals
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
Browse market analysis articles for data-driven insight into venture capital trends.
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Anthropic's mega-round dominated May, while defense, enterprise AI, space, and infrastructure financings show where large U.S. checks still cleared.
May's New York funding sample spans AI infrastructure, retail, wealth management, health, and SMB banking; the useful pattern is measurable workflow adoption.
D2C food brand Anveshan raised ₹121 crore (~$12.7M) Series B led by Vertex Ventures and IFC in May 2026, roughly doubling its valuation on a rural-sourcing model.
C2i Semiconductors raised a $16.7M Series A extension led by TDK Ventures and Peak XV in May 2026, advancing India's push into semiconductor design.
Corgi Insurance stacked a $160M Series B and a $106M Series B1 within weeks in May 2026, reaching a $2.6B valuation for its AI-native insurance platform.